Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Microbot Medical Inc.

< Previous 1 2 3 4 Next >
News headline image
Microbot Medical® Receives Its First International Regulatory Approval for the Commercialization of the LIBERTY® Endovascular Robotic System
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical to Hold Analysts and Investors Conference Call to Review Recent Progress; Executive Team will be Joined by Current Users of the LIBERTY Endovascular Robotic System, Dr. Charles Briggs and Dr. Zachary Bercu
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical Successfully Transitions to Commercial Operations as It Records Revenue Resulting from Its Limited Market Release During the First Quarter of 2026
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical®’s LIBERTY® Endovascular Robotic System is Now Adopted by Multiple Accounts Across Key Territories Including Two ACCESS-PVI Pivotal Clinical Trial Sites
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical® Announces the Addition of Senior Commercial Executive with Proven Track Record to Accelerate Commercial Readiness in Europe, the Middle East, and Asia (EMEA)
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical® Welcomes Updated Occupational Protection Guidelines from Leading Medical Societies, Strengthening Commercial Position of LIBERTY®
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical® to Highlight Commercial Achievements Leading to the Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System at the 25th Annual Needham Virtual Healthcare Conference
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical® Commences Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System in the U.S. at the Society of Interventional Radiology (SIR) Annual Scientific Meeting
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Emory Healthcare Successfully Completes Robotic Peripheral Endovascular Procedures using Microbot Medical®’s LIBERTY® Endovascular Robotic System
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical® Strengthens LIBERTY® Endovascular Robotic System Position with Publication of its ACCESS PVI Pivotal Study in Leading Peer-Reviewed Medical Journal
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical® to Participate at the 38th Annual Roth Conference
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical® to Participate at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference for The First Time
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical® Aligns with Recently Adopted Policy of the Largest U.S.-Based Medical Association to Expand Protection for Healthcare Professionals from Ionizing Radiation
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical® Confirms Continued Operational and Commercial Stability Amid Current Geopolitical Event
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Tampa General Hospital is the First Health System in Florida to Adopt the LIBERTY® Endovascular Robotic System
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical®’s LIBERTY® Endovascular Robotic System Continues to Expand Market Visibility; Being Featured at an Industry Leading Innovation Conference
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical®’s LIBERTY® Endovascular Robotic System Highlighted at a Leading Vascular Disease Management Conference
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical® to Leverage Current Users Experience of the LIBERTY® Endovascular Robotic System at Key Oncology Conference to Support Commercial Adoption
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical Continues its 2025 Momentum; Announces Key 2026 Milestones
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical® Announces Emory University Hospital as the First Hospital in the World to Adopt the New LIBERTY® Endovascular Robotic System
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical® Secures U.S. Based Logistics Partner to Support the Commercialization of Its LIBERTY® Endovascular Robotic System
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Miocrbot Medical® CEO to Discuss Recent FDA Clearance of the LIBERTY® Endovascular Robotic System
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for Up to $92.2 Million in Gross Proceeds
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
REMINDER: Microbot Medical to Highlight FDA 510(k) Clearance of the LIBERTY Endovascular Robotic System at the H.C. Wainwright Annual Investor Conference
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.